Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

LEO 90100 in the Treatment of Psoriasis Vulgaris

ClinicalTrials.gov ID: NCT01536938

Public ClinicalTrials.gov record NCT01536938. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01536938
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
LEO Pharma
Industry
Enrollment
303 participants

Conditions and interventions

Interventions

  • LEO 90100 Drug
  • Calcipotriol Drug
  • Betamethasone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
Aug 31, 2012
Completion
Oct 31, 2012
Last update posted
Mar 6, 2025

2012

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Dermatology Research Associates Los Angeles California 90045
Dermatology Specialists, Inc. Oceanside California 92056
Skin Surgery Medical Group, Inc San Diego California 92117
University Clinical Trials, Inc. San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Colorado Medical Research Center, Inc Denver Colorado 80210
Horizons Clinical Research Center Denver Colorado 80220
Dermatology Associates and Research Coral Gables Florida 33134
North Florida Dermatology Associates, PA Jacksonville Florida 32204
International Dermatology Research, Inc. Miami Florida 33144
Altman Dermatology Associates Arlington Heights Illinois 60005
Glazer Dermatology Buffalo Grove Illinois 60089
Clinical Research Advantage, Inc./Hudson Dermatology, LLC Evansville Indiana 47714
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46256
The Indiana Clinical Trials Center Plainfield Indiana 46168
Owensboro Dermatology Associates Owensboro Kentucky 42303
David Fivenson, MD, PLC Ann Arbor Michigan 48103
Great Lakes Research Group, Inc. Bay City Michigan 48706
Derm Center Troy Michigan 48084
Grekin Skin Institute Warren Michigan 48008
Minnesota Clinical Study Center Fridley Minnesota 55432
Psoriasis Treatment Center of Central NJ East Windsor New Jersey 08520
The Dermatology Group, PC Verona New Jersey 07044
Derm Research Center of New York Stony Brook New York 11790
Philadelphia Institute of Dermatology Fort Washington Pennsylvania 19034
Menter Dermatology Research Institute Dallas Texas 75246
Center for Clinical Studies Houston Texas 77065
Clinical Trials of Texas, Inc San Antonio Texas 78229
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Progressive Clinical Research San Antonio Texas 78229
Virginia Clinical Research, Inc. Norfolk Virginia 23507
Premier Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01536938, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01536938 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →